Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, Colorado.
Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado.
Am J Respir Crit Care Med. 2020 Dec 1;202(11):1520-1530. doi: 10.1164/rccm.201910-2021OC.
Noninvasive ventilation decreases the need for invasive mechanical ventilation and mortality among patients with chronic obstructive pulmonary disease but has not been well studied in asthma. To assess the association between noninvasive ventilation and subsequent need for invasive mechanical ventilation and in-hospital mortality among patients admitted with asthma exacerbation to the ICU. We performed a retrospective cohort study using administrative data collected during 2010-2017 from 682 hospitals in the United States. Outcomes included receipt of invasive mechanical ventilation and in-hospital mortality. Generalized estimating equations, propensity-matched models, and marginal structural models were used to assess the association between noninvasive ventilation and outcomes. The study population included 53,654 participants with asthma exacerbation. During the study period, 13,540 patients received noninvasive ventilation (25.2%; 95% confidence interval [CI], 24.9-25.6%), 14,498 underwent invasive mechanical ventilation (27.0%; 95% CI, 26.7-27.4%), and 1,291 died (2.4%; 95% CI, 2.3-2.5%). Among those receiving noninvasive ventilation, 3,013 patients (22.3%; 95% CI, 21.6-23.0%) required invasive mechanical ventilation after first receiving noninvasive ventilation, 136 of whom died (4.5%; 95% CI, 3.8-5.3%). Across all models, the use of noninvasive ventilation was associated with a lower odds of receiving invasive mechanical ventilation (adjusted generalized estimating equation odds ratio, 0.36; 95% CI, 0.32-0.40) and in-hospital mortality (odds ratio, 0.48; 95% CI 0.40-0.58). Those who received noninvasive ventilation before invasive mechanical ventilation were more likely to have comorbid pneumonia and severe sepsis. Noninvasive ventilation use during asthma exacerbation was associated with improved outcomes but should be used cautiously with acute comorbid conditions.
无创通气可降低慢性阻塞性肺疾病患者的有创机械通气需求和死亡率,但在哮喘患者中研究甚少。本研究旨在评估无创通气与因哮喘加重而入住 ICU 的患者随后需要有创机械通气和院内死亡率之间的相关性。我们使用美国 682 家医院在 2010 年至 2017 年期间收集的行政数据进行了回顾性队列研究。结果包括接受有创机械通气和院内死亡率。广义估计方程、倾向评分匹配模型和边缘结构模型用于评估无创通气与结果之间的相关性。研究人群包括 53654 名哮喘加重患者。在研究期间,13540 名患者接受了无创通气(25.2%;95%置信区间[CI],24.9-25.6%),14498 名患者接受了有创机械通气(27.0%;95% CI,26.7-27.4%),1291 名患者死亡(2.4%;95% CI,2.3-2.5%)。在接受无创通气的患者中,有 3013 名患者(22.3%;95% CI,21.6-23.0%)在首次接受无创通气后需要接受有创机械通气,其中 136 名患者死亡(4.5%;95% CI,3.8-5.3%)。在所有模型中,使用无创通气与接受有创机械通气的可能性较低相关(调整后的广义估计方程比值比,0.36;95% CI,0.32-0.40)和院内死亡率(比值比,0.48;95% CI 0.40-0.58)。那些在接受有创机械通气之前接受无创通气的患者更有可能合并肺炎和严重脓毒症。在哮喘加重期间使用无创通气与改善结果相关,但应谨慎用于急性合并症。